Drug-coated balloon versus stent angioplasty in patients with intracranial atherosclerotic stenosis: A systematic review and meta-analysis.

Authors

Aya Magdy Siam, Omar Fayez Abbas, Nour Aldin T Ahmed, Roaa Haddad, Abdelrahman M Hamouda, Sherief Ghozy, Kogulavadanan Arumaithurai, Ram Kadirvel, Farhan Siddiq, David Kallmes

Published in

Journal of the neurological sciences. Volume 491. Pages 126214. Oct 12, 2026. Epub Oct 12, 2026.

Abstract

Intracranial Atherosclerotic Stenosis (ICAS) is one of the leading causes of ischemic stroke worldwide. Endovascular interventions such as drug-coated balloon (DCB) angioplasty and stent angioplasty (SA) have emerged as promising treatment options, particularly for patients with severe stenosis. However, the comparative efficacy and safety of these two approaches remain uncertain. This systematic review aimed to compare the efficacy and safety of DCB versus SA in patients with ICAS.
A comprehensive search of PubMed, Scopus, Web of Science, Embase, and the Cochrane Central was conducted through January 2026. We included randomized clinical trials and comparative cohort studies that compare DCB with SA in patients with ICAS.
Six studies comprising 723 participants (332 DCB, 391 SA) met the inclusion criteria. The mean participant age ranged from 55.3 to 66.33 years. Compared with SA, DCB was associated with a lower overall restenosis rate (RR = 0.28, 95% CI: 0.18 to 0.44, p = 0.0007, I² = 0.0%, τ² = 0, PI = 0.16 to 0.48), and recurrent ischemic events (RR = 0.30, 95% CI: 0.22 to 0.42, p = 0.0002, I² = 0.0%, τ² = 0, PI = 0.13 to 0.72). No statistically significant difference in periprocedural complications was observed between the two strategies (RR = 0.78, 95% CI: 0.39 to 1.55, p = 0.3878, I² = 0.0%, τ² ≤0.0001, PI = 0.35 to 1.73).
DCB is associated with greater efficacy than SA in reducing restenosis and recurrent ischemic events in patients with ICAS without increasing procedural complications. However, interpretation of these findings is limited by the predominance of nonrandomized studies and relatively short follow-up durations. More randomized clinical trials with longer follow-up and larger sample sizes are needed.

PMID:
42927686
Bibliographic data and abstract were imported from PubMed on 26 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.